Cost–effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, MA Joore, AJ ten Cate-Hoek… - Biomarkers in …, 2014 - Future Medicine
Aim: The objective of this study was to explore the cost–effectiveness of D-dimer biomarker
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, MA Joore, AJ ten Cate-Hoek… - Biomarkers in …, 2014 - pubmed.ncbi.nlm.nih.gov
Aim The objective of this study was to explore the cost-effectiveness of D-dimer biomarker
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, MA Joore… - Biomarkers in …, 2014 - cris.maastrichtuniversity.nl
Aim: The objective of this study was to explore the cost-effectiveness of D-dimer biomarker
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients.
A Vaidya, MA Joore, AJ ten Cate-Hoek… - Biomarkers in …, 2014 - europepmc.org
Aim The objective of this study was to explore the cost-effectiveness of D-dimer biomarker
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, MA Joore, AJ ten Cate-Hoek… - Biomarkers in …, 2014 - go.gale.com
Background Peripheral arterial disease (PAD) affects a large proportion of adult populations
worldwide. The prevalence of PAD ranges between 3 and 10% and rises with age reaching …
worldwide. The prevalence of PAD ranges between 3 and 10% and rises with age reaching …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, M Joore, T Cate-Hoek, J Arina… - Biomarkers in …, 2014 - repub.eur.nl
__Abstract__ Aim: The objective of this study was to explore the cost–effectiveness of D-
dimer biomarker and the societal value (headroom) of a hypothetical perfect biomarker for …
dimer biomarker and the societal value (headroom) of a hypothetical perfect biomarker for …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, MA Joore, AJ Ten Cate-Hoek… - Biomarkers in …, 2014 - search.proquest.com
Aim: The objective of this study was to explore the cost-effectiveness of D-dimer biomarker
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
Cost-effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
A Vaidya, M Joore, T Cate-Hoek, J Arina… - Biomarkers in …, 2014 - repub.eur.nl
Aim: The objective of this study was to explore the cost-effectiveness of D-dimer biomarker
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …
and the societal value (headroom) of a hypothetical perfect biomarker for risk assessment …